Knockdown of YAP/TAZ sensitizes tamoxifen-resistant MCF7 breast cancer cells

In conclusion, targeting the YAP/TAZ-PSAT1 axis could sensitize tamoxifen-resistant MCF7 breast cancer cells by modulating the mTORC1-survivin axis.PMID:35231654 | DOI:10.1016/j.bbrc.2022.02.083
Source: Cell Research - Category: Cytology Authors: Source Type: research